Analysen des hämatopoetischen Chimärismus - TOBIAS-lib ...

(13) Bader P, Kreyenberg H, Hoelle W, Dueckers G, Handgretinger R, Lang P,
Kremens B, Dilloo D, Sykora KW, Schrappe M, Niemeyer C, Von
Stackelberg A, Gruhn B, Henze G, Greil J, Niethammer D, Dietz K, Beck J,
Klingbiel T. Increasing mixed chimerism is an important prognostic factor
for unfavorable outcome in children with acute lymphoblastic leukemia
after allogeneic stem-cell transplantation: possible role for pre-emptive
immunotherapy? j clin oncol 2004; 22:1696-705.
(14) Bader P, Kreyenberg H, Hoelle W, Dueckers G, Kremens B, Dilloo D,
Sykora KW, Niemeyer C, Reinhardt D, Vormoor J, Gruhn B, Lang P, Greil
J, Handgretinger R, Niethammer D, Klingbiel T, Beck J. Increasing mixed
chimerism defines a high-risk group of childhood acute myelogenous
leukemia patientes after allogeneic stem cell transplantation where preemptive
immunotherapy may be effective. Bone Marrow Transplant 2004;
33:815-21.
(15) Bader P, Beck J, Frey A, Schlegel PG, Hebarth H, Handgretinger R,
Einsele H, Niemeyer C, Benda N, Faul C, Kanz L, Niethammer D,
Klingebiel T. Serial and quantitative analysis of mixed hematopoietic
chimerism by PCR in patients with acute leukemias allows the prediction of
relapse after allogeneic BMT. Bone Marrow Transplant 1998; 21(5):487-
495.
(16) Bader P, Hoelle W, Klingbiel T, Handgretinger R, Niethammer D, Beck J.
Quantitative assessment of mixed haematopoetic chimerism by
polymerase chain reaction after allogeneic BMT. Anticancer research
1996; 16.
(17) Bader P, Holle W, Klingebiel T, Handgretinger R, Benda N, Schlegel PG,
Niethammer D, Beck J. Mixed hematopoetic chimerism after allogenic
bone marrow transplantation: the impact of quantitative PCR analysis for
prediction of relapse and graft rejection in children. Bone Marrow
Transplant 1997; 19(7):697-702.
(18) Bader P, Klingebiel T, Schaudt A, Theurer-Mainka U, Handgretinger R,
Lang P, Niethammer D, Beck JF. Prevention of relapse in pediatric
patients with acute leukemias and MDS after allogeneic SCT by early
immunotherapy initiated on the basis of increasing mixed chimerism: a
single centre experience of 12 children. Leukemia 1999; 13(12):2079-
2086.
(19) Bader P, Niethammer D, Willasch A, Kreyenberg H, Klingebiel T. How and
when should we monitor chimerism after allogeneic stem cell
transplantation? Bone Marrow Transplant 2005; 35(2):107-119.
(20) Bader P, Stoll K, Huber S, Geiselhart A, Handgretinger R, Niemeyer C,
Einsele H, Schlegel PG, Niethammer D, Beck J, Klingebiel T.
Characterization of lineage-specific chimaerism in patients with acute
leukaemia and myelodysplastic syndrome after allogenic stem cell
77